Don’t Miss the Latest
Life Science and Healthcare Information

When you subscribe to the d-Wise blog, you’ll get the latest
industry trends, news and tips right in your inbox!

No, thanks. I don‘t need to stay current.

d-Wise Life Science’s Team Excels with 3 Top Presentations at PhUSE-London 2014

Phuse 2014_winners_(1)The Pharmaceutical Users Software Exchange (PhUSE) celebrated its 10th anniversary during their Annual Conference on 13 October in London. Since its inception, PhUSE has been a “Not-for-profit” organization run by volunteers but has continually expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of critical life science industry topics.

The conference this year brought together more than 500 Data Managers, Biostatisticians, Statistical Programmers and eClinical professionals from over 50 different global pharmaceutical and biotech organizations, contract research organizations and technology solution providers, consultants and regulatory agencies. 

New this year were dedicated sessions on Data Transparency and an industry led discussion on Cloud Computing led by Amazon, British Telecom (BT) and top 10 pharma companies including GSK and AstraZeneca.

While the main topic for the event was Clinical Trial Transparency, the 3 day conference included over 100 presentations across multiple streams including topics such as Application Development, , CDISC & Industry Standards, Data Handling, Regulatory, Technical Solutions, Trends & Technology, and Data Transparency. 

d-Wise Life Science consultants were awarded top presentation honors in three separate categories… more than any other company that participated.

  • Ali Dootson, d-Wise Life Sciences Director, Europe won top honors with a presentation on, Agile Project Management in a Regulated Environment, where he identified the differences  between SCRUM development and Agile Development for a SAS Drug Development migration from version 3.5 to version 4.5.
  • Cathal Gallagher, a d-Wise Life Sciences Consultant based in the UK, won top honours with a presentation on, Reducing Programming Time with Reusable Templates, which demonstrated the value of using validated programming templates for CDISC transformations, a topic that also won top awards at the PhUSE FDA/CSS conference in the spring.
  • Ian Fleming, d-Wise Principal Life Sciences Consultant won top prize for his presentation on The Application of Directed Graphs to Clinical Development where he applied graph theory  which allows the dynamic linking of multiple concepts  to clinical research.

“It is fantastic to see our consultants recognized at events like PhUSE for their insight and expertise around industry trends and best practices. I was especially impressed with the creativity they demonstrated in presenting their stories as well as in the solutions they choose to highlight.” said John Leveille, d-Wise CEO. “We’ve been an active supporter of PhUSE for many years, and we were glad to be an integral part of this special 10th anniversary event and sponsor the Gala. d-Wise is passionate about technology innovation in Life Sciences, but we are particularly excited to be on the forefront of software development projects that focus on data de-identification in this new era of data transparency”.

d-Wise provides a unique combination of domain expertise and technology knowledge that is hard to find. Led by world experts in clinical trials, health analytics, data standards and emerging technologies, d-Wise empowers organizations to solve their data and business process challenges by bringing together people, processes, data and technology to deliver on a client’s vision. By rapidly harnessing data, integrating systems and aligning critical business needs and challenges, d-Wise solutions provide a solid foundation toward improving care and reducing costs in healthcare.

If you would like to learn more about d-Wise's expertise and the knowledge we have to offer, please view our papers and resources here.

Share

About the Author

Leave a Comment